Location History:
- Beaconsfield, GB (2016)
- London, GB (2017 - 2020)
Company Filing History:
4 out of 282 
4 out of 10 
4 out of 260 
Years Active: 2016-2025
Title: John McVey: Innovator in Blood Clotting Factor Research
Introduction
John McVey is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the area of blood clotting factors. With a total of 4 patents to his name, McVey's work has the potential to impact medical treatments significantly.
Latest Patents
One of McVey's latest patents involves an optimized coding sequence of human blood clotting factor eight (VIII) and a promoter. This innovation may be utilized in vectors, such as rAAV, for the introduction of factor VIII and other blood clotting factors and transgenes. The exemplary factors and transgenes include alpha-1-antitrypsin, as well as those involved in the coagulation cascade, hepatocyte biology, lysosomal storage, urea cycle disorders, and lipid storage diseases. The cells, vectors, proteins, and glycoproteins produced by cells transformed by these vectors and sequences may be used in treatment.
Career Highlights
Throughout his career, John McVey has worked with various organizations, including UCL Business Plc and the Thrombosis Research Institute. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of blood clotting research.
Collaborations
Some of McVey's notable coworkers include Amit Nathwani and Natalie Ward. Their collaborative efforts have contributed to advancements in the understanding and treatment of blood-related disorders.
Conclusion
John McVey's contributions to the field of biotechnology, particularly in blood clotting factors, demonstrate his commitment to innovation and medical advancement. His patents and collaborations reflect a dedication to improving treatment options for patients with blood disorders.